Women with axial spondyloarthritis face longer diagnostic delays and greater disease burden than men despite higher rates of treatment and healthy behaviors, according to data published in International Journal of Rheumatic Diseases. “Although [axial SpA (axSpA)] can affect both males and females, there are differences in gender in terms of prevalence, clinical presentation, disease
Submit your Case Report to present unusual or novel experiences which may be educational for your colleagues in the field of rheumatology.
EULAR Research Funding The EULAR Research Centre offers several funding opportunities for researchers and health professionals in rheumatology. Please find below more information about our…
Chin PYK, Regan W, Plausinis D, Zarzour Z, Leung F, Johnston K, Lim B, Sasyniuk T. A multicenter, randomized controlled trial comparing a second-generation uncemented…
Although the recently published treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica suggest minimising the use of glucocorticoids,1 these drugs are still the standard…
This study suggests that, compared with placebo, individuals with polymyalgia rheumatica receiving 4 mg baricitinib are less likely to need oral glucocorticoids to have low…
Maintaining healthful behaviors may be key to improving the trajectory of heart health from early adolescence into adulthood, according to study findings published in JAMA…
EULAR invites you to submit an abstract to EULAR 2025, the European Congress of Rheumatology. Every year EULAR invites abstract submitters from all over the…
Symptoms of pelvic floor (PF) dysfunction are highly prevalent in female athletes at all levels of sports participation.1 One in three women across all sports…
Robotic arm-assisted medial compartment knee arthroplasty is a cost-effective intervention at ten-year follow-up
For the second time since 2019, the oral SGLT1 and SGLT2 dual inhibitor sotagliflozin has been denied FDA approval for adults with type 1 diabetes,…
